To Be A Global Outstanding Life Science Company With Innovative Drug Solutions
To Be A Global Outstanding Life Science Company With Innovative Drug Solutions
Jiuzhou Pharma—CDMO for Innovative Drugs
about Us
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (Abbreviated Name: Jiuzhou Pharma, Stock Code: 603456.SH), founded in 1998 and headquartered in Taizhou, Zhejiang, is a leading contract development and manufacturing organization (CDMO) of small molecules and peptide APIs that successfully evolved from a generic API manufacturer. We provide pharmaceutical companies worldwide with one-stop innovative drug development and manufacturing solutions and services throughout the development lifecycle of an innovative drug—from preclinical chemical manufacturing and control (CMC) through phase I/II/III clinical trials and new drug applications (NDA) to commercialization.
As a leader in green pharmaceutical manufacturing, we have developed frontier environmentally friendly pharmaceutical technologies with independent intellectual property rights. We are committed to providing our customers with industry-leading technical solutions that enhance R&D efficiency and success while reducing costs.
Serve Life, Guard Health - we are committed to being a distinguished global life science company that provides innovative drug solutions to help our partners accelerate the time to market of innovative drugs and benefit patients worldwide.
core competitiveness
Competitive advantage throughout the product life cycle.
Based on deep process innovation capabilities and continuous lean cost control capabilities in commercial production, continuous production process optimization and supply chain system improvement for customers' marketed drugs to ensure the market competitiveness of customers' commercialized products.
New drug listing
Promote the rapid launch of new drugs based on successful comprehensive professional service capabilities to support the global NDA launch of new drugs for customers.
Early Clinical Program
Based on the leading professional technology platform and professional pharmaceutical research capabilities, to achieve the rapid delivery of early clinical projects.
Commitment to pharmaceutical R&D and innovation
With the inception of the company in 1973, starting with the production of monosodium glutamate (MSG), we later evolved to provide pharmaceutical companies worldwide with one-stop CDMO services and specialty generics.
Business locations worldwide (countries and regions)
Our business spans across major pharmaceutical markets in Asia, America, Europe, Africa, and Australia, as well as high-growth emerging markets worldwide.
Employees worldwide
Our company consists of a multi-disciplinary team of world-class professionals. (as of 2024)
Global partners
Including world-renowned pharmaceutical companies (Novartis, Roche, Zoetis, Daiichi Sankyo) and leading innovative pharma companies in China (HUTCHMED, Betta Pharmaceuticals, Haihe Biopharma, Luye Pharma).
Service Platform
News
Sustainability
sustainable development
We are committed to working with our stakeholders to continue strengthening our practices around environmental stewardship, social responsibility, and corporate governance to build a sustainable future together.
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
Established Business Services（API）
Tel: 86-576-88881561
E-mail: bd@jiuzhoupharma.com
